Nonalcoholic Fatty Liver Disease
- PMID: 27154894
- DOI: 10.18043/ncm.77.3.216
Nonalcoholic Fatty Liver Disease
Abstract
Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is the leading cause of chronic liver disease. Treatments target lifestyle modification and improvement of underlying risk factors. Noninvasive biomarkers for diagnosis and staging of NAFLD and safe, cost-effective treatments for patients with nonalcoholic steatohepatitis (NASH) and/or NASH-related cirrhosis are currently under investigation.
©2016 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical